- Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infectionAmy S Sturt
Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
Pediatr Infect Dis J 31:53-60. 2012..The effect of timing of HAART initiation on reduction of morbidity is not well defined. We evaluated the association of timing of HAART initiation on progression to moderate or severe disease...
- Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenAmy S Sturt
Division of Infectious Diseases, Stanford University, 300 Pasteur Drive, S 101, Stanford, California, USA, 94305
Cochrane Database Syst Rev 3:CD008440. 2010..Specifically, AZT/3TC/NVP, AZT/3TC/LPV-r, and AZT/3TC/ABC have been shown to decrease MTCT. More research is needed regarding the use of specific regimens and their maternal and infant side-effect profiles...